Alan Minsk Quoted in Pink Sheet on FDA Advertising Enforcement Trends

Alan Minsk, AGG Food & Drug practice chair, was quoted in an article for Pink Sheet analyzing how FDA’s recent advertising enforcement actions have reshaped drug promotion.

Alan noted that the volume and pace of enforcement activity was “head spinning,” stressing the growing scrutiny life sciences companies face when communicating product claims.

For drug and device companies, the enforcement surge highlights the importance of proactive promotional review and compliance strategies to mitigate regulatory risk.

To read the full article, please click here (subscription required).